National Academies Press: OpenBook
« Previous: 8 Visionary Statements on Priorities for Innovation
Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×

References

Amman, B. R., S. A. Carroll, Z. D. Reed, T. K. Sealy, S. Balinandi, R. Swanepoel, A. Kemp, B. R. Erickson, J. A. Comer, S. Campbell, D. L. Cannon, M. L. Khristova, P. Atimnedi, C. D. Paddock, R. J. Crockett, T. D. Flietstra, K. L. Warfield, R. Unfer, E. Katongole-Mbidde, R. Downing, J. W. Tappero, S. R. Zaki, P. E. Rollin, T. G. Ksiazek, S. T. Nichol, and J. S. Towner. 2012. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLOS Pathogens 8(10):e1002877.

Ansah, E. K., M. Gyapong, S. Narh-Bana, C. Bart-Plange, and C. J. Whitty. 2016. Factors influencing choice of care-seeking for acute fever comparing private chemical shops with health centres and hospitals in Ghana: A study using case-control methodology. Malaria Journal 15(1):290.

Bandyopadhyay, A. S. 2019. Applying lessons learned from innovation in polio eradication. PowerPoint presented at the workshop on Exploring the Frontiers of Innovation to Tackle Microbial Threats, Washington, DC.

Bandyopadhyay, A. S., J. Garon, K. Seib, and W. A. Orenstein. 2015. Polio vaccination: Past, present and future. Future Microbiology 10(5):791–808.

Bhatt, S., D. J. Weiss, E. Cameron, D. Bisanzio, B. Mappin, U. Dalrymple, K. E. Battle, C. L. Moyes, A. Henry, D. L. Smith, P. W. Gething, P. A. Eckhoff, E. A. Wenger, O. Briet, M. A. Penny, T. A. Smith, O. Briet, M. A. Penny, T. A. Smith, A. Bennett, J. Yukich, T. P. Eisele, J. T. Griffin, C. A. Fergus, M. Lynch, R. E. Cibulskis, F. Lindgren, J. M. Cohen, C. L. J. Murray, D. L. Smith, S. I. Hay, D. L. Smith, D. L. Smith, S. I. Hay, and S. I. Hay. 2015. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 526(7572):207–211.

Bill & Melinda Gates Foundation. n.d. Polio. https://www.gatesfoundation.org/what-we-do/global-development/polio (accessed March 3, 2020).

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×

Buckee, C. O., M. I. E. Cardenas, J. Corpuz, A. Ghosh, F. Haque, J. Karim, A. S. Mahmud, R. J. Maude, K. Mensah, N. V. Motaze, M. Nabaggala, C. J. E. Metcalf, S. A. Mioramalala, F. Mubiru, C. M. Peak, S. Pramanik, J. M. Rakotondramanga, E. Remera, I. Sinha, S. Sovannaroth, A. J. Tatem, and W. Zaw. 2018. Productive disruption: Opportunities and challenges for innovation in infectious disease surveillance. BMJ Global Health 3(1):e000538.

CCA (Council of Canadian Academies). 2019. When Antibiotics Fail. Ottawa, ON, Canada: The Expert Panel on the Potential Socio-Economic Impacts of Antimicrobial Resistance in Canada, Council of Canadian Academies.

CDC (U.S. Centers for Disease Control and Prevention). 2018. Deadly Marburg virus found in Sierra Leone bats. https://www.cdc.gov/media/releases/2018/p1220-marburg-found-in-bats.html (accessed February 18, 2020).

CDC. 2019a. Ebola (Ebola Virus Disease): Signs and symptoms. https://www.cdc.gov/vhf/ebola/symptoms/index.html (accessed March 3, 2020).

CDC. 2019b. Years of Ebola virus disease outbreaks. https://www.cdc.gov/vhf/ebola/history/chronology.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvhf%2Febola%2Foutbreaks%2Fhistory%2Fchronology.html (accessed March 4, 2020).

CDC. 2019c. Preparedness pays off with quick response time. https://www.cdc.gov/globalhealth/stories/ebola-preparedness.html (accessed March 4, 2020).

CDC. 2020. One Health. https://www.cdc.gov/onehealth/index.html (accessed March 26, 2020).

Chang, H. H., A. Mahmud, R. J. Maude, C. Buckee, H. H. Chang, A. Mahmud, R. J. Maude, C. Buckee, A. Wesolowski, I. Sinha, D. Uddin, S. I. Zaman, M. A. Faiz, M. Dhorda, O. Miotto, R. J. Maude, I. Sinha, M. Dhorda, R. J. Maude, C. G. Jacob, E. Drury, S. Goncalves, M. Kekre, O. Miotto, D. Kwiatkowski, M. A. Hossain, M. A. Faiz, A. Ghose, A. A. Sayeed, M. R. Rahman, A. Islam, M. J. Karim, M. M. Aktaruzzaman, M. K. Rezwan, A. K. M. Shamsuzzaman, S. T. Jhora, M. Dhorda, R. Vongpromek, O. Miotto, D. Kwiatkowski, and K. Engo-Monsen. 2019. Mapping imported malaria in Bangladesh using parasite genetic and human mobility data. eLife 8.

Cheng, M., R. Satter, and J. Goodman. 2016. Few Zika samples are being shared by Brazil, worrying international researchers. Associated Press, February 3, 2016.

Cima, G. 2020. Pandemic prevention program ending after 10 years: USAID PREDICT led virus discovery, health training, risk education. Journal of the American Veterinary Medical Association News. https://www.avma.org/javma-news/2020-01-15/pandemic-prevention-program-ending-after-10-years (accessed March 5, 2020).

Cochi, S. L., and W. R. Dowdle. 2013. Disease eradication in the 21st century: Implications for global health. Cambridge, MA: The MIT Press.

Crozier, I. 2016. Ebola virus rna in the semen of male survivors of Ebola virus disease: The uncertain gravitas of a privileged persistence. Journal of Infectious Diseases 214(10):1467–1469.

DFID (Department for International Development). 2019. UK aid to help vaccinate more than 400 million children a year against polio. https://www.gov.uk/government/news/uk-aid-to-help-vaccinate-more-than-400-million-children-a-year-against-polio (accessed March 4, 2020).

Diallo, B., D. Sissoko, N. J. Loman, H. A. Bah, H. Bah, M. C. Worrell, L. S. Conde, R. Sacko, S. Mesfin, A. Loua, J. K. Kalonda, N. A. Erondu, B. A. Dahl, S. Handrick, I. Goodfellow, L. W. Meredith, M. Cotten, U. Jah, R. E. Guetiya Wadoum, P. Rollin, N. Magassouba, D. Malvy, X. Anglaret, M. W. Carroll, R. B. Aylward, M. H. Djingarey, A. Diarra, P. Formenty, S. Keôta, S. Günther, A. Rambaut, and S. Duraffour. 2016. Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days. Clinical Infectious Diseases 63(10):1353–1356.

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×

Domenici, L., M. Monti, C. Bracchi, M. Giorgini, V. Colagiovanni, L. Muzii, and P. Benedetti Panici. 2016. D-mannose: A promising support for acute urinary tract infections in women. A pilot study. European Review for Medical and Pharmacological Science 20(13):2920–2925.

Dosani, R. F. 2019. Fostering new partnerships to enable innovation. PowerPoint presented at the workshop on Exploring the Frontiers of Innovation to Tackle Microbial Threats, Washington, DC.

Dusfour, I., J. Vontas, J., David, D. Weetman, D. M. Fonseca, V. Corbel, K. Raghavendra, M. B. Coullibaly, A. J. Martins, S. Kasai, and F. Chandre. 2019. Management of insecticide resistance in the major Aedes vectors of arboviruses: Advances and challenges. PLOS Neglected Tropical Diseases 13(10):e0007615.

Dutra, H. L., M. N. Rocha, F. B. Dias, S. B. Mansur, E. P. Caragata, and L. A. Moreira. 2016. Wolbachia blocks currently circulating Zika virus isolates in Brazilian Aedes Aegypti mosquitoes. Cell Host and Microbe 19(6):771–774.

Dzau, V. J., G. S. Ginsburg, A. Chopra, D. Goldman, E. D. Green, D. G. B. Leonard, M. McClellan, A. Plump, S. F. Terry, and K. R. Yamamoto. 2016. Realizing the full potential of precision medicine in health and health care: A vital direction for health and health care. NAM Perspectives. Discussion Paper, National Academy of Medicine, Washington, DC. https://doi.org/10.31478/201609k.

FDA (U.S. Food and Drug Administration). 2014. First rapid home-use HIV kit approved for self-testing. https://www.fda.gov/consumers/consumer-updates/first-rapid-home-use-hiv-kit-approved-self-testing (accessed March 4, 2020).

Forbes, K. M., P. W. Webala, A. J. Jaaskelainen, S. Abdurahman, J. Ogola, M. M. Masika, I. Kivisto, H. Alburkat, I. Plyusnin, L. Levanov, E. M. Korhonen, E. Huhtamo, D. Mwaengo, T. Smura, A. Mirazimi, O. Anzala, O. Vapalahti, and T. Sironen. 2019. Bombali virus in Mops condylurus bat, Kenya. Emerging Infectious Diseases 25(5).

Freudenthal, E. 2019. Ebola’s lost blood: Row over samples flown out of Africa as “big pharma” set to cash in. The Telegraph, February 6, 2019.

Frost, I., J. Craig, J. Joshi, K. Faure, and R. Laxminarayan. 2019. Access barriers to antibiotics. Washington, DC: Center for Disease Dynamics, Economics & Policy.

Gage, J. C., and P. E. Castle. 2010. Preventing cervical cancer globally by acting locally: If not now, when? Journal of the National Cancer Institute 102(20):1524–1527.

Gandra, S., J. Joshi, A. Trett, A. Sankhil Lamkang, and R. Laxminarayan. 2017. Scoping report on antimicrobial resistance in India. Washington, DC: Center for Disease Dynamics, Economics & Policy.

Goalkeepers. 2016. Case study: Child mortality. https://datareport.goalkeepers.org/case-studies/child-mortality (accessed February 2, 2020).

Goldstein, T., B. H. Bird, A. Tremeau-Bravard, M. N. Belaganahalli, J. K. Dhanota, B. R. Smith, C. Monagin, C. K. Johnson, J. A. K. Mazet, S. J. Anthony, H. L. Wells, E. Liang, M. Grodus, W. I. Lipkin, S. J. Anthony, W. I. Lipkin, S. J. Anthony, E. Liang, A. Gbakima, J. Bangura, R. K. Jangra, V. A. DeJesus, K. Chandran, G. Lasso, S. Shapira, A. Jambai, B. O. Kamara, S. Kamara, W. Bangura, C. Monagin, K. Saylors, E. M. Rubin, and S. Shapira. 2018. The discovery of Bombali virus adds further support for bats as hosts of Ebola viruses. Nature Microbiology 3(10):1084–1089.

Grayson, K. 2016. Cultivating trust is critical—and surprisingly complex. Kellogg Insight. https://insight.kellogg.northwestern.edu/article/cultivating-trust-is-critical-and-surprisingly-complex (accessed March 4, 2020).

Hallsworth, M., T. Chadborn, A. Sallis, M. Sanders, D. Berry, F. Greaves, L. Clements, and S. C. Davies. 2016. Provision of social norm feedback to high prescribers of antibiotics in general practice: A pragmatic national randomised controlled trial. The Lancet 387(10029):1743–1752.

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×

Haynes, K. E., and A. S. Fotheringham. 1984. Gravity and spacial interaction models. Beverly Hills, CA: Sage.

Hendriksen, R. S., P. Munk, P. Njage, B. van Bunnik, L. McNally, O. Lukjancenko, T. Roder, D. Nieuwenhuijse, S. K. Pedersen, J. Kjeldgaard, R. S. Kaas, P. Clausen, J. K. Vogt, P. Leekitcharoenphon, M. G. M. van de Schans, T. Zuidema, A. M. de Roda Husman, S. Rasmussen, B. Petersen, Global Sewage Surveillance Project Consortium, C. Amid, G. Cochrane, T. Sicheritz-Ponten, H. Schmitt, J. R. M. Alvarez, A. Aidara-Kane, S. J. Pamp, O. Lund, T. Hald, M. Woolhouse, M. P. Koopmans, H. Vigre, T. N. Petersen, and F. M. Aarestrup. 2019. Global monitoring of antimicrobial resistance based on metagenomics analyses of urban sewage. Nature Communications 10(1):1124.

Hu, L., D. Bell, S. Antani, Z. Xue, K. Yu, M. P. Horning, N. Gachuhi, B. Wilson, M. S. Jaiswal, B. Befano, L. R. Long, R. Herrero, M. H. Einstein, R. D. Burk, M. Demarco, J. C. Gage, A. C. Rodriguez, N. Wentzensen, and M. Schiffman. 2019. An observational study of deep learning and automated evaluation of cervical images for cancer screening. Journal of the National Cancer Institute 111(9):923–932.

Human Vaccines Project. 2020. A new approach to fighting disease. https://www.humanvaccinesproject.org (accessed March 5, 2020).

IVCC (Innovative Vector Control Consortium). n.d. New Nets Project (NNP). https://www.ivcc.com/market-access/new-nets-project (accessed February 18, 2020).

Janssen, R., N. Engel, A. Esmail, S. Oelofse, A. Krumeich, K. Dheda, and N. P. Pai. 2020. Alone but supported: A qualitative study of an HIV self-testing app in an observational cohort study in South Africa. AIDS and Behavior 24(2):467–474.

Jonas, O. B., A. Irwin, F. C. J. Berthe, F. G. Le Gall, and P. V. Marquez. 2017. Drug-resistant infections: A threat to our economic future. Washington, DC: HNP/Agriculture Global Antimicrobial Resistance Initiative.

Jusu, M. O., G. Glauser, J. F. Seward, M. Bawoh, J. Tempel, M. Friend, D. Littlefield, M. Lahai, H. M. Jalloh, A. B. Sesay, A. F. Caulker, M. Samai, V. Thomas, N. Farrell, and M. A. Widdowson. 2018. Rapid establishment of a cold chain capacity of –60 degrees C or colder for the STRIVE Ebola vaccine trial during the Ebola outbreak in Sierra Leone. Journal of Infectious Diseases 217(Suppl 1):S48–S55.

Kahn, R., A. S. Mahmud, A. Schroeder, L. H. Aguilar Ramirez, J. Crowley, J. Chan, and C. O. Buckee. 2019. Rapid forecasting of cholera risk in Mozambique: Translational challenges and opportunities. Prehospital and Disaster Medicine 34(5):557–562.

Kahneman, D. 2003. A perspective on judgment and choice: Mapping bounded rationality. American Psychologist 58(9):697.

Karim, S. S. A., and C. Baxter. 2019. HIV incidence rates in adolescent girls and young women in sub-Saharan Africa. Lancet Global Health 7(11):e1470–e1471.

Keegan, S. 2014. Kiss of death: Defiant farmers still smooching camels despite deadly virus warnings. Mirror, May 14, 2014.

Kim, W. 2019. Sparking antibiotic discovery through data sharing and scientific collaboration. PowerPoint presented at the workshop on Exploring the Frontiers of Innovation to Tackle Microbial Threats, Washington, DC.

Koopmans, M., X. de Lamballerie, T. Jaenisch, K. D. Rosenberger, I. Morales, E. T. A. Marques, I. F. T. Viana, P. Brasil, R. Rabello, V. I. Avelino-Silva, A. Segurado, N. Alexander, P. Mayaud, E. M. Netto, A. Tami, S. Bethencourt, M. Consuelo Miranda, A. Lozano, C. Soria, S. P. Salgado Cisneros, E. Gotuzzo, M. G. Guzmán, P. A. M. Rodriguez, H. Lopez-Gatell, J. Hegewisch-Taylor, V. H. Borja-Aburto, C. Gonzales Bonilla, B. Hoen, M. van Roode, and B. Rockx. 2019. Familiar barriers still unresolved—A perspective on the Zika virus outbreak research response. The Lancet Infectious Diseases 19(2):e59–e62.

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×

Kruk, M. E., A. D. Gage, C. Arsenault, K. Jordan, H. H. Leslie, S. Roder-DeWan, O. Adeyi, P. Barker, B. Daelmans, S. V. Doubova, M. English, E. G. Elorrio, F. Guanais, O. Gureje, L. R. Hirschhorn, L. Jiang, E. Kelley, E. T. Lemango, J. Liljestrand, A. Malata, T. March-ant, M. P. Matsoso, J. G. Meara, M. Mohanan, Y. Ndiaye, O. F. Norheim, K. S. Reddy, A. K. Rowe, J. A. Salomon, G. Thapa, N. A. Y. Twum-Danso, and M. Pate. 2018. High-quality health systems in the sustainable development goals era: Time for a revolution. Lancet Global Health 6(11):e1196–e1252.

Kupferschmidt, K. 2019. Successful Ebola treatments promise to tame outbreak. Science 365(6454):628–629.

Lenhart, A. 2019. The role of innovation in the evolution of global vector control response. PowerPoint presented at the workshop on Exploring the Frontiers of Innovation to Tackle Microbial Threats, Washington, DC.

Liu, V., M. P. Clark, M. Mendoza, R. Saket, M. N. Gardner, B. J. Turk, and G. J. Escobar. 2013. Automated identification of pneumonia in chest radiograph reports in critically ill patients. BMC Medical Informatics and Decision Making 13:90.

Mabud, T. S., M. de Lourdes Delgado Alves, A. I. Ko, S. Basu, K. S. Walter, T. Cohen, B. Mathema, C. Colijn, E. Lemos, J. Croda, and J. R. Andrews. 2019. Evaluating strategies for control of tuberculosis in prisons and prevention of spillover into communities: An observational and modeling study from brazil. PLOS Medicine 16(3).

McMullan, L. K., M. Flint, A. Chakrabarti, L. Guerrero, M. K. Lo, D. Porter, S. T. Nichol, C. F. Spiropoulou, and C. Albarino. 2019. Characterisation of infectious ebola virus from the ongoing outbreak to guide response activities in the democratic republic of the congo: A phylogenetic and in vitro analysis. The Lancet Infectious Diseases 19(9):1023–1032.

Meeker, D., T. K. Knight, M. W. Friedberg, J. A. Linder, N. J. Goldstein, C. R. Fox, A. Rothfeld, G. Diaz, and J. N. Doctor. 2014. Nudgying guideline-concordant antibiotic prescribing: A randomized clinical trial. JAMA Internal Medicine 174(3):425–431.

Moran, M., J. Guzman, K. Henderson, R. Liyanage, L. Wu, E. Chin, N. Chapman, L. Abela-Oversteegen, D. Gouglas, and D. Kwong. 2012. Neglected disease research and development: A five year review. Sydney, Australia: Policy Cures.

Moreira, L. A., I. Iturbe-Ormaetxe, J. A. Jeffery, G. Lu, A. T. Pyke, L. M. Hedges, B. C. Rocha, S. Hall-Mendelin, A. Day, M. Riegler, L. E. Hugo, K. N. Johnson, B. H. Kay, E. A. McGraw, A. F. van den Hurk, P. A. Ryan, and S. L. O’Neill. 2009. A Wolbachia symbiont in Aedes aegypti limits infection with dengue, chikungunya, and plasmodium. Cell 139(7):1268–1278.

Narra, R., J. Sobel, C. Piper, D. Gould, N. Bhadelia, M. Dott, A. Fiore, W. A. Fischer, M. J. Frawley, P. M. Griffin, D. Hamilton, B. Mahon, S. K. Pillai, E. F. Veltus, R. Tauxe, and M. Jhung. 2017. CDC safety training course for Ebola virus disease health workers. Emerging Infectious Diseases 23(13):S217–S224.

Ozawa, S., S. Clark, A. Portnoy, S. Grewal, M. L. Stack, A. Sinha, A. Mirelman, H. Franklin, I. K. Friberg, and Y. Tam. 2017. Estimated economic impact of vaccinations in 73 low- and middle-income countries, 2001–2020. Bulletin of the World Health Organization 95(9):629.

Pant Pai, N., J. Sharma, S. Shivkumar, S. Pillay, C. Vadnais, L. Joseph, K. Dheda, and R. W. Peeling. 2013a. Supervised and unsupervised self-testing for HIV in high- and low-risk populations: A systematic review. PLOS Medicine 10(4):e1001414.

Pant Pai, N., T. Behlim, L. Abrahams, C. Vadnais, S. Shivkumar, S. Pillay, A. Binder, R. DeliHoussein, N. Engel, L. Joseph, and K. Dheda. 2013b. Will an unsupervised self-testing strategy for HIV work in health care workers of South Africa? A cross sectional pilot feasibility study. PLOS ONE 8(11):e79772.

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×

Pant Pai, N., J. Sharma, B. Balram, M. Bhargava, S. Pillay, L. Joseph, and P. P. Tellier. 2014. Will an unsupervised self-testing strategy be feasible to operationalize in Canada? Results from a pilot study in students of a large Canadian university. AIDS Research and Treatment 2014:747619.

Pant Pai, N., M. Smallwood, L. Desjardins, A. Goyette, K. G. Birkas, A. F. Vassal, L. Joseph, and R. Thomas. 2018. An unsupervised smart app-optimized HIV self-testing program in Montreal, Canada: Cross-sectional study. Journal of Medical Internet Research 20(11):e10258.

Pettitt, J., E. Higgs, M. Fallah, M. Nason, E. Stavale, J. Marchand, C. Reilly, K. Jensen, B. Dighero-Kemp, K. Tuznik, J. Logue, F. Bolay, and L. Hensley. 2017. Assessment and optimization of the GeneXpert diagnostic platform for detection of Ebola virus RNA in seminal fluid. Journal of Infectious Diseases 215(4):547–553.

Platt, L. R., C. F. Estivariz, and R. W. Suttler. 2014. Vaccine-associated paralytic poliomyelitis: A review of the epidemiology and estimation of the global burden. Journal of Infectious Diseases 210(Suppl 1):S380–S389.

Raftery, P., O. Condell, C. Wasunna, J. Kpaka, R. Zwizwai, M. Nuha, M. Fallah, M. Freeman, V. Harris, M. Miller, A. Baller, M. Massaquoi, V. Katawera, J. Saindon, P. Bemah, E. Hamblion, E. Castle, D. Williams, A. Gasasira, T. Nyenswah, and E. Mossel. 2018. Establishing Ebola virus disease (EVD) diagnostics using genexpert technology at a mobile laboratory in Liberia: Impact on outbreak response, case management and laboratory systems strengthening. PLOS Neglected Tropical Diseases 12(1):e0006135.

Ribeiro, C. D. S., M. Y. van Roode, G. B. Haringhuizen, M. P. Koopmans, E. Claassen, and L. H. M. van de Burgwal. 2018a. How ownership rights over microorganisms affect infectious disease control and innovation: A root-cause analysis of barriers to data sharing as experienced by key stakeholders. PLOS ONE 13(5).

Ribeiro, C. D. S., M. P. Koopmans, and G. B. Haringhuizen. 2018b. Threats to timely sharing of pathogen sequence data. Science 362(6413):404–406.

Roberts, L. 2020. Global polio eradication falters in the final stretch. Science 367(6473):14–15.

Roscigno, G., Y. Yuthavong, and L. Manderson. 2012. Innovation and new technologies to tackle infectious diseases of poverty. In Global Report for Research on Infectious Diseases of Poverty, edited by M. Harris and J. N. Reza. Geneva, Switzerland: World Health Organization. Pp. 94–114.

Saha, S. 2019. Unbiased metagenomic sequencing to counter microbial threats: Lessons from Bangladesh. PowerPoint presented at the workshop on Exploring the Frontiers of Innovation to Tackle Microbial Threats, Washington, DC.

Saha, S., S. Saha, and S. K. Saha. 2018. Barriers in Bangladesh. Elife 7.

Saha, S., A. Ramesh, K. Kalantar, R. Malaker, M. Hasanuzzaman, L. M. Khan, M. Y. Mayday, M. S. I. Sajib, L. M. Li, C. Langelier, H. Rahman, E. D. Crawford, C. M. Tato, M. Islam, Y. F. Juan, C. de Bourcy, B. Dimitrov, J. Wang, J. Tang, J. Sheu, R. Egger, T. R. De Carvalho, M. R. Wilson, S. K. Saha, and J. L. DeRisi. 2019a. Unbiased metagenomic sequencing for pediatric meningitis in Bangladesh reveals neuroinvasive chikungunya virus outbreak and other unrealized pathogens. mBio 10(6).

Saha, S., M. M. H. Afrad, S. Saha, and S. K. Saha. 2019b. Towards making global health research truly global. Lancet Global Health 7(9):e1175.

Sands, P. 2018. Ending epidemics and building health systems. https://www.theglobalfund.org/en/blog/2018-10-12-ending-epidemics-and-building-health-systems (accessed March 16, 2020).

Semper, A. E., M. J. Broadhurst, J. Richards, G. M. Foster, A. J. Simpson, C. H. Logue, J. D. Kelly, A. Miller, T. J. Brooks, M. Murray, and N. R. Pollock. 2016. Performance of the GeneXpert Ebola assay for diagnosis of Ebola virus disease in Sierra Leone: A field evaluation study. PLOS Medicine 13(3):e1001980.

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×

Stenberg, K., O. Hanssen, T. T. Edejer, M. Bertram, C. Brindley, A. Meshreky, J. E. Rosen, J. Stover, P. Verboom, R. Sanders, and A. Soucat. 2017. Financing transformative health systems towards achievement of the health sustainable development goals: A model for projected resource needs in 67 low-income and middle-income countries. Lancet Global Health 5(9):e875–e887.

Sullivan, N. J., A. Sanchez, P. E. Rollin, Z. Y. Yang, and G. J. Nabel. 2000. Development of a preventive vaccine for Ebola virus infection in primates. Nature 408(6812):605–609.

Swanepoel, R., S. B. Smit, P. E. Rollin, P. Formenty, P. A. Leman, A. Kemp, F. J. Burt, A. A. Grobbelaar, J. Croft, D. G. Bausch, H. Zeller, H. Leirs, L. E. Braack, M. L. Libande, S. Zaki, S. T. Nichol, T. G. Ksiazek, J. T. Paweska, S. International, and the Technical Committee for Marburg Hemorrhagic Fever Control in the Democratic Republic of the Congo. 2007. Studies of reservoir hosts for marburg virus. Emerging Infectious Diseases 13(12):1847–1851.

Talkington, K., C. Shore, and P. Kothari. 2016. A scientific roadmap for antibiotic discovery. Philiadelphia, PA: The Pew Charitable Trusts.

Thaler, R. H., and C. R. Sunstein. 2009. Nudge: Improving decisions about health, wealth, and happiness. New York: Penguin.

The Pew Charitable Trusts. 2018. Achaogen provides data to SPARK, Pew’s platform for antibiotic discovery research. https://www.pewtrusts.org/en/about/news-room/press-releases-and-statements/2018/10/22/achaogen-provides-data-to-spark-pews-platform-for-antibiotic-discovery-research (accessed February 2, 2020).

The Pew Charitable Trusts. 2019a. Tracking the global pipeline of antibiotics in development. https://www.pewtrusts.org/en/research-and-analysis/issue-briefs/2019/09/tracking-the-global-pipeline-of-antibiotics-in-development (accessed March 5, 2020).

The Pew Charitable Trusts. 2019b. Novartis provides data to SPARK, Pew’s platform for antibiotic discovery research. https://www.pewtrusts.org/en/about/news-room/press-releases-and-statements/2019/01/03/novartis-provides-data-to-spark-pews-platform-for-antibiotic-discovery-research (accessed February 2, 2020).

The Pew Charitable Trusts. 2019c. Novartis shares 2 new datasets with SPARK, Pew’s antibiotic discovery tool. https://www.pewtrusts.org/en/research-and-analysis/articles/2019/05/10/novartis-shares-2-new-datasets-with-spark-pews-antibiotic-discovery-tool (accessed February 2, 2020).

Towner, J. S. 2019. Advancing innovation on the ground in the fight against Ebola (a CDC perspective). PowerPoint presented at the workshop on Exploring the Frontiers of Innovation to Tackle Microbial Threats, Washington, DC.

Towner, J. S., T. K. Sealy, M. L. Khristova, C. G. Albarino, S. Conlan, S. A. Reeder, P. L. Quan, W. I. Lipkin, R. Downing, J. W. Tappero, S. Okware, J. Lutwama, B. Bakamutumaho, J. Kayiwa, J. A. Comer, P. E. Rollin, T. G. Ksiazek, and S. T. Nichol. 2008. Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLOS Pathogens 4(11):e1000212.

Towner, J. S., B. R. Amman, T. K. Sealy, S. A. Carroll, J. A. Comer, A. Kemp, R. Swanepoel, C. D. Paddock, S. Balinandi, M. L. Khristova, P. B. Formenty, C. G. Albarino, D. M. Miller, Z. D. Reed, J. T. Kayiwa, J. N. Mills, D. L. Cannon, P. W. Greer, E. Byaruhanga, E. C. Farnon, P. Atimnedi, S. Okware, E. Katongole-Mbidde, R. Downing, J. W. Tappero, S. R. Zaki, T. G. Ksiazek, S. T. Nichol, and P. E. Rollin. 2009. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLOS Pathogens 5(7):e1000536.

UNAIDS (Joint United Nations Programme on HIV/AIDS). 2014. 90-90-90: An ambitious treatment target to help end the AIDS epidemic. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS.

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×

USAID (U.S. Agency for International Development). 2019a. Private-sector engagement evidence and learning plan. https://www.usaid.gov/work-usaid/private-sector-engagement/evidence-and-learning-plan (accessed February 2, 2020).

USAID. 2019b. Private-sector engagement policy. https://www.usaid.gov/sites/default/files/documents/1865/usaid_psepolicy_final.pdf (accessed February 2, 2020).

Van Damme, P., I. Coster, A. S. Bandyopadhyay, L. Suykens, P. Rudelsheim, P. Neels, M. S. Oberste, W. C. Weldon, R. Clemens, and H. Revets. 2019a. Poliopolis: Pushing boundaries of scientific innovations for disease eradication. Future Microbiology 14(15):1321–1330.

Van Damme, P., I. De Coster, A. S. Bandyopadhyay, H. Revets, K. Withanage, P. De Smedt, L. Suykens, M. S. Oberste, W. C. Weldon, S. A. Costa-Clemens, R. Clemens, J. Modlin, A. J. Weiner, A. J. Macadam, R. Andino, O. M. Kew, J. L. Konopka-Anstadt, C. C. Burns, J. Konz, R. Wahid, and C. Gast. 2019b. The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: A double-blind, single-centre phase 1 study. Lancet 394(10193):148–158.

van den Hurk, A. F., S. Hall-Mendelin, A. T. Pyke, F. D. Frentiu, K. McElroy, A. Day, S. Higgs, and S. L. O’Neill. 2012. Impact of Wolbachia on infection with chikungunya and yellow fever viruses in the mosquito vector Aedes aegypti. PLOS Neglected Tropical Diseases 6(11):e1892.

van Vuren, P. J., A. Grobbelaar, N. Storm, O. Conteh, K. Konneh, A. Kamara, I. Sanne, and J. T. Paweska. 2016. Comparative evaluation of the diagnostic performance of the prototype Cepheid GeneXpert Ebola assay. Journal of Clinical Microbiology 54(2):359–367.

Wesolowski, A., T. Qureshi, M. F. Boni, P. R. Sundsoy, M. A. Johansson, S. B. Rasheed, K. Engo-Monsen, and C. O. Buckee. 2015. Impact of human mobility on the emergence of dengue epidemics in Pakistan. Proceedings of the National Academy of Sciences of the United States of America 112(38):11887–11892.

WHO (World Health Organization). 2015. Global action plan on antimicrobial resistance. https://apps.who.int/iris/handle/10665/193736 (accessed March 5, 2020).

WHO. 2016. HIV self-testing and partner notification. Geneva, Switzerland: World Health Organization.

WHO. 2017a. Global vector control response 2017–2030. Geneva, Switzerland: World Health Organization.

WHO. 2017b. Invasive bacterial vaccine preventable diseases laboratory network. https://www.who.int/immunization/monitoring_surveillance/burden/laboratory/IBVPD/en (accessed March 3, 2020).

WHO. 2018a. World malaria report 2018. Geneva, Switzerland: World Health Organization.

WHO. 2018b. Resource mobilisation for antimicrobial resistance (AMR): Getting AMR into plans and budgets of government and development partners: Nepal country report. Geneva, Switzerland: World Health Organization.

WHO. 2019a. Poliomyelitis: Key facts. https://www.who.int/news-room/fact-sheets/detail/poliomyelitis (accessed February 20, 2020).

WHO. 2019b. Two out of three wild poliovirus strains eradicated. https://www.who.int/news-room/feature-stories/detail/two-out-of-three-wild-poliovirus-strains-eradicated (accessed February 20, 2020).

WHO. 2019c. What is vaccine-derived polio? https://www.who.int/features/qa/64/en (accessed February 20, 2020).

WHO. 2019d. HIV self-testing. https://www.who.int/hiv/topics/self-testing/en (accessed March 4, 2020).

WHO. 2019e. WHO guidelines on tuberculosis infection prevention and control. Geneva, Switzerland: World Health Organization.

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×

WHO. 2019f. Immunization coverage: Key facts. https://www.who.int/news-room/fact-sheets/detail/immunization-coverage (accessed February 20, 2020).

WHO. 2019g. Turning plans into action for antimicrobial resistance (AMR)—Working paper 2.0: Implementation and coordination. Geneva, Switzerland: World Health Organization.

WHO. 2020. Ebola virus disease: Key facts. https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease (accessed March 3, 2020).

Ye, Y. H., A. M. Carrasco, F. D. Frentiu, S. F. Chenoweth, N. W. Beebe, A. F. van den Hurk, C. P. Simmons, S. L. O’Neill, and E. A. McGraw. 2015. Wolbachia reduces the transmission potential of dengue-infected Aedes aegypti. PLOS Neglected Tropical Diseases 9(6):e0003894.

Yozwiak, N. L., S. F. Schaffner, and P. C. Sabeti. 2015. Data sharing: Make outbreak research open access. Nature 518(7540):477–479.

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×

This page intentionally left blank.

Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×
Page 125
Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×
Page 126
Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×
Page 127
Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×
Page 128
Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×
Page 129
Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×
Page 130
Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×
Page 131
Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×
Page 132
Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×
Page 133
Suggested Citation:"References." National Academies of Sciences, Engineering, and Medicine. 2020. Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25746.
×
Page 134
Next: Appendix A: Workshop Statement of Task »
Exploring the Frontiers of Innovation to Tackle Microbial Threats: Proceedings of a Workshop Get This Book
×
Buy Paperback | $70.00
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

On December 4–5, 2019, the National Academies of Sciences, Engineering, and Medicine held a 1.5-day public workshop titled Exploring the Frontiers of Innovation to Tackle Microbial Threats. The workshop participants examined major advances in scientific, technological, and social innovations against microbial threats. Such innovations include diagnostics, vaccines (both development and production), and antimicrobials, as well as nonpharmaceutical interventions and changes in surveillance. This publication summarizes the presentations and discussions from the workshop.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!